Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding-Reference-Cited by-同舟云学术

Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding

Published:2020-01-01 Issue:1 Volume:59 Page:93-99
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Fujita Yoko¹,Terashita Maho¹,Yazawa Masahiko¹,Yamasaki Yukitaka²,Imamura Tomonori³,Kibayashi Junichiro⁴,Sawai Toshihiro⁵,Hidaka Yoshihiko⁶⁷,Ohtani Katsuki⁷⁸,Inoue Norimitsu⁶⁷,Shibagaki Yugo¹

Affiliation:

1. Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan

2. Department of Infectious Disease, St. Marianna University School of Medicine, Japan

3. Department of Emergency and Critical Care Medicine, Tokyo Metropolitan Police Hospital, Japan

4. Department of Obstetrics and Gynecology, Yokohama General Hospital, Japan

5. Department of Pediatrics, Shiga University of Medical Science, Japan

6. Department of Molecular Genetics, Wakayama Medical University, Japan

7. The Japanese Association for Complement Research, Japan

8. Department of Food and Health Sciences, Rakuno Gakuen University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/1/59_3315-19/_pdf

Reference18 articles.

1. 1. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med 361: 1676-1687, 2009.

2. 2. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med 371: 654-666, 2014.

3. 3. Noris M, Caprioli J, Bresin E, et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5: 1844-1859, 2010.

4. 4. Asif A, Nayer A, Haas CS. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab. J Nephrol 30: 347-362, 2017.

5. 5. Riedl M, Fakhouri F, Le Quintrec M, et al. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 40: 444-464, 2014.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical hemolytic uremic syndrome after myomectomy: A case report;Case Reports in Women's Health;2022-07

2. Clinical features and outcomes of four atypical hemolytic uremic syndrome cases at a single institution in Miyazaki Prefecture from 2015 to 2019;Renal Replacement Therapy;2022-04-11

3. The evaluation of a scoring system for diagnosing atypical hemolytic uremic syndrome;Thrombosis Update;2020-12

4. Eculizumab;Reactions Weekly;2020-05